AU2001280959A1 - Analysis of biological samples for platelet activation or coagulation activationmarkers using microparticules - Google Patents

Analysis of biological samples for platelet activation or coagulation activationmarkers using microparticules

Info

Publication number
AU2001280959A1
AU2001280959A1 AU2001280959A AU8095901A AU2001280959A1 AU 2001280959 A1 AU2001280959 A1 AU 2001280959A1 AU 2001280959 A AU2001280959 A AU 2001280959A AU 8095901 A AU8095901 A AU 8095901A AU 2001280959 A1 AU2001280959 A1 AU 2001280959A1
Authority
AU
Australia
Prior art keywords
activationmarkers
microparticules
coagulation
analysis
biological samples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280959A
Inventor
Michael R Henry
David C Leahy
Ronald J. Shebuski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAREPOINT DIAGNOSTICS Inc
Original Assignee
CAREPOINT DIAGNOSTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAREPOINT DIAGNOSTICS Inc filed Critical CAREPOINT DIAGNOSTICS Inc
Publication of AU2001280959A1 publication Critical patent/AU2001280959A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
AU2001280959A 2000-08-01 2001-08-01 Analysis of biological samples for platelet activation or coagulation activationmarkers using microparticules Abandoned AU2001280959A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22220400P 2000-08-01 2000-08-01
US60222204 2000-08-01
US29912901P 2001-06-18 2001-06-18
US60299129 2001-06-18
PCT/US2001/024132 WO2002010771A1 (en) 2000-08-01 2001-08-01 Analysis of biological samples for platelet activation or coagulation activation markers using microparticules

Publications (1)

Publication Number Publication Date
AU2001280959A1 true AU2001280959A1 (en) 2002-02-13

Family

ID=26916545

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280959A Abandoned AU2001280959A1 (en) 2000-08-01 2001-08-01 Analysis of biological samples for platelet activation or coagulation activationmarkers using microparticules

Country Status (3)

Country Link
US (1) US20020076833A1 (en)
AU (1) AU2001280959A1 (en)
WO (1) WO2002010771A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100016A1 (en) * 2001-11-23 2003-05-29 George Jackowski Complement C3 precursor biopolymer markers predictive of Alzheimers disease
EP1355158A1 (en) 2002-04-19 2003-10-22 B.R.A.H.M.S Aktiengesellschaft Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker
US7141369B2 (en) 2002-04-25 2006-11-28 Semibio Technology, Inc. Measuring cellular metabolism of immobilized cells
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
US20060024744A1 (en) * 2004-07-28 2006-02-02 Mills Rhonda A Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
EP1890155A1 (en) * 2006-08-17 2008-02-20 F. Hoffmann-Roche AG Methods and means for determining platelet function and diagnosing platelet-related and cardiovascular disorders
CN102230935A (en) * 2011-04-13 2011-11-02 苏州博赛生物医药有限公司 High-flux fluorescent McAb nanometer microsphere kit
WO2013076157A1 (en) 2011-11-22 2013-05-30 Universite Catholique De Louvain Marker for blood coagulation
EP2829878A1 (en) * 2013-07-23 2015-01-28 Siemens Healthcare Diagnostics Products GmbH Method for determining GPIb receptor-dependent platelet function
CN106526193B (en) * 2015-09-10 2018-05-15 中国科学院上海高等研究院 Protein G P1BA/VWF is used as the application of the molecular labeling of detection diabetes B

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335181C (en) * 1988-10-11 1995-04-11 R. Alan Hardwick System for selective cell separation from cell concentrate
US5646001A (en) * 1991-03-25 1997-07-08 Immunivest Corporation Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
DE4228395A1 (en) * 1992-08-26 1994-03-03 Loeliger Christoph Cornelius D Immuno-absorbent for allo-antibody determn. - comprising magnetic carrier particles coated with monoclonal antibody bonding with target antigen
CA2348612A1 (en) * 1998-10-23 2000-05-04 Barry S. Coller Method for determining platelet count
US6586259B1 (en) * 1999-11-15 2003-07-01 Pharmanetics Incorporated Platelet/leukocyte interaction assay and reagent therefor

Also Published As

Publication number Publication date
US20020076833A1 (en) 2002-06-20
WO2002010771A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
AU1733100A (en) Devices and methods for performing blood coagulation assays by piezoelectric sensing
DE50013029D1 (en) Sample chamber for liquid treatment of biological samples
AU2001297014A1 (en) An integrated biochip system for sample preparation and analysis
AU2003302138A1 (en) Scanning of biological samples
GB2362711B (en) Analysis of samples
AU8615501A (en) Quantitative analysis of hexose-monophosphates from biological samples
WO2002077640A8 (en) Systems for analysis of biological materials
AU2001280959A1 (en) Analysis of biological samples for platelet activation or coagulation activationmarkers using microparticules
AU2002312858A1 (en) Device and method for the optical measurement of chemical and/or biological samples
AU2789299A (en) Unique identifier for biological samples
GB2362710B (en) Analysis of samples
AU2002216092A1 (en) Method and device for determining the topology of biological tissue
AU2000280282A1 (en) Diagnostic assay for a sample of biological fluid
AU2709401A (en) Detection of biological target
AU6350300A (en) Method for chemical analysis of biological material
AU2003219362A1 (en) Chemical analysis of samples
AU2002368207A1 (en) Coded particles for multiplexed analysis of biological samples
AU2001276523A1 (en) Aspiration of samples
AU2002212520A1 (en) Analysis of biological and biochemical assays
AU6418200A (en) Analysis of biological fluids
GB2361699B (en) Analysis of complex biological mixtures
AU2001256264A1 (en) Device for implementing chemical or biological methods
AU2001230556A1 (en) Biological component contacting instrument
GB0031610D0 (en) Difference analysis of biological samples
AU2002216285A1 (en) Multiple target test useful for pre-donation screening of blood